(6-Methoxy-1H-indol-2-yl)(4-(2-(4-methoxyphenoxy)ethyl)piperazin-1-yl)methanone

ID: ALA4540693

PubChem CID: 38417721

Max Phase: Preclinical

Molecular Formula: C23H27N3O4

Molecular Weight: 409.49

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(OCCN2CCN(C(=O)c3cc4ccc(OC)cc4[nH]3)CC2)cc1

Standard InChI:  InChI=1S/C23H27N3O4/c1-28-18-5-7-19(8-6-18)30-14-13-25-9-11-26(12-10-25)23(27)22-15-17-3-4-20(29-2)16-21(17)24-22/h3-8,15-16,24H,9-14H2,1-2H3

Standard InChI Key:  AOEZTGSRIVCHEA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   14.0635  -13.5040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0611  -12.6827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7717  -12.2678    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3480  -12.2721    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4867  -12.6823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1952  -12.2709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1970  -11.4493    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4841  -11.0406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7694  -11.4495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9050  -11.0412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6165  -11.4504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3287  -11.0424    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0402  -11.4515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0355  -12.2713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7462  -12.6845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4593  -12.2723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4573  -11.4468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7461  -11.0414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1714  -12.6847    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.1718  -13.5060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4014  -13.9847    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7318  -13.9807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4776  -14.7628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6602  -14.7634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2558  -15.4711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6637  -16.1786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4843  -16.1741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8890  -15.4658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2569  -16.8874    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.4397  -16.8894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  3  5  1  0
  3  9  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  1  0
  1 21  1  0
 21 24  1  0
 23 22  1  0
 22  1  2  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 26 29  1  0
 29 30  1  0
M  END

Associated Targets(Human)

DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 409.49Molecular Weight (Monoisotopic): 409.2002AlogP: 3.02#Rotatable Bonds: 7
Polar Surface Area: 67.03Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.53CX LogP: 2.47CX LogD: 2.41
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.65Np Likeness Score: -1.17

References

1. Moritz AE, Free RB, Weiner WS, Akano EO, Gandhi D, Abramyan A, Keck TM, Ferrer M, Hu X, Southall N, Steiner J, Aubé J, Shi L, Frankowski KJ, Sibley DR..  (2020)  Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist.,  63  (10): [PMID:32342685] [10.1021/acs.jmedchem.0c00424]

Source